The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Fluralaner API Market Research Report 2025
Synopsis
Fluralaner, isoxazoline class compound, is a systemic insecticide and acaricide with antiparasitic activity against cat and dog fleas and ticks. Fluralaner is an inhibitor of the arthropod nervous system. Fluralaner inhibits γ-aminobutyric acid (GABA)-gated chloride channels (GABACls) and L-glutamate-gated chloride channels (GluCls). Potency of fluralaner is comparable to fipronil (a phenylpyrazole ectoparasiticide). Fluralaner API in this report.
The global Fluralaner API market was valued at US$ 67 million in 2023 and is anticipated to reach US$ 101 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.
Global key manufacturers of Fluralaner API include Nissan Chemical, Hikal, Hubei Masteam Bio-tech, Jiangsu Rivocean, Shaanxi Dideu, etc. Global top five manufacturers hold a share about 85%. Asia-Pacific is the largest market of Fluralaner API, holds a share over 35%. In terms of product, purity above 98% ones hold a larger segment, with a share over 75%. And in terms of application, the largest application is oral drug, with a share of over 70%.
This report aims to provide a comprehensive presentation of the global market for Fluralaner API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fluralaner API.
Report Scope
The Fluralaner API market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fluralaner API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fluralaner API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Nissan Chemical
Hikal
Hubei Masteam Bio-tech
Jiangsu Rivocean
Shaanxi Dideu
Zhejiang Gihi Chemicals
Hunan Huateng Pharmaceutical
Taizhou Crene Biotechnology
Segment by Type
Purity above 98%
Purity below 98%
Segment by Application
Oral Drug
Topical Drug
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fluralaner API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fluralaner API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Fluralaner, isoxazoline class compound, is a systemic insecticide and acaricide with antiparasitic activity against cat and dog fleas and ticks. Fluralaner is an inhibitor of the arthropod nervous system. Fluralaner inhibits γ-aminobutyric acid (GABA)-gated chloride channels (GABACls) and L-glutamate-gated chloride channels (GluCls). Potency of fluralaner is comparable to fipronil (a phenylpyrazole ectoparasiticide). Fluralaner API in this report.
The global Fluralaner API market was valued at US$ 67 million in 2023 and is anticipated to reach US$ 101 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.
Global key manufacturers of Fluralaner API include Nissan Chemical, Hikal, Hubei Masteam Bio-tech, Jiangsu Rivocean, Shaanxi Dideu, etc. Global top five manufacturers hold a share about 85%. Asia-Pacific is the largest market of Fluralaner API, holds a share over 35%. In terms of product, purity above 98% ones hold a larger segment, with a share over 75%. And in terms of application, the largest application is oral drug, with a share of over 70%.
This report aims to provide a comprehensive presentation of the global market for Fluralaner API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fluralaner API.
Report Scope
The Fluralaner API market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fluralaner API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fluralaner API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Nissan Chemical
Hikal
Hubei Masteam Bio-tech
Jiangsu Rivocean
Shaanxi Dideu
Zhejiang Gihi Chemicals
Hunan Huateng Pharmaceutical
Taizhou Crene Biotechnology
Segment by Type
Purity above 98%
Purity below 98%
Segment by Application
Oral Drug
Topical Drug
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fluralaner API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fluralaner API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Fluralaner API Market Overview
1.1 Product Overview and Scope of Fluralaner API
1.2 Fluralaner API Segment by Type
1.2.1 Global Fluralaner API Market Value Comparison by Type (2024-2030)
1.2.2 Purity above 98%
1.2.3 Purity below 98%
1.3 Fluralaner API Segment by Application
1.3.1 Global Fluralaner API Market Value by Application: (2024-2030)
1.3.2 Oral Drug
1.3.3 Topical Drug
1.4 Global Fluralaner API Market Size Estimates and Forecasts
1.4.1 Global Fluralaner API Revenue 2019-2030
1.4.2 Global Fluralaner API Sales 2019-2030
1.4.3 Global Fluralaner API Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Fluralaner API Market Competition by Manufacturers
2.1 Global Fluralaner API Sales Market Share by Manufacturers (2019-2024)
2.2 Global Fluralaner API Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Fluralaner API Average Price by Manufacturers (2019-2024)
2.4 Global Fluralaner API Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Fluralaner API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Fluralaner API, Product Type & Application
2.7 Fluralaner API Market Competitive Situation and Trends
2.7.1 Fluralaner API Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Fluralaner API Players Market Share by Revenue
2.7.3 Global Fluralaner API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Fluralaner API Retrospective Market Scenario by Region
3.1 Global Fluralaner API Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Fluralaner API Global Fluralaner API Sales by Region: 2019-2030
3.2.1 Global Fluralaner API Sales by Region: 2019-2024
3.2.2 Global Fluralaner API Sales by Region: 2025-2030
3.3 Global Fluralaner API Global Fluralaner API Revenue by Region: 2019-2030
3.3.1 Global Fluralaner API Revenue by Region: 2019-2024
3.3.2 Global Fluralaner API Revenue by Region: 2025-2030
3.4 North America Fluralaner API Market Facts & Figures by Country
3.4.1 North America Fluralaner API Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Fluralaner API Sales by Country (2019-2030)
3.4.3 North America Fluralaner API Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Fluralaner API Market Facts & Figures by Country
3.5.1 Europe Fluralaner API Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Fluralaner API Sales by Country (2019-2030)
3.5.3 Europe Fluralaner API Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fluralaner API Market Facts & Figures by Country
3.6.1 Asia Pacific Fluralaner API Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Fluralaner API Sales by Country (2019-2030)
3.6.3 Asia Pacific Fluralaner API Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Fluralaner API Market Facts & Figures by Country
3.7.1 Latin America Fluralaner API Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Fluralaner API Sales by Country (2019-2030)
3.7.3 Latin America Fluralaner API Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Fluralaner API Market Facts & Figures by Country
3.8.1 Middle East and Africa Fluralaner API Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Fluralaner API Sales by Country (2019-2030)
3.8.3 Middle East and Africa Fluralaner API Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Fluralaner API Sales by Type (2019-2030)
4.1.1 Global Fluralaner API Sales by Type (2019-2024)
4.1.2 Global Fluralaner API Sales by Type (2025-2030)
4.1.3 Global Fluralaner API Sales Market Share by Type (2019-2030)
4.2 Global Fluralaner API Revenue by Type (2019-2030)
4.2.1 Global Fluralaner API Revenue by Type (2019-2024)
4.2.2 Global Fluralaner API Revenue by Type (2025-2030)
4.2.3 Global Fluralaner API Revenue Market Share by Type (2019-2030)
4.3 Global Fluralaner API Price by Type (2019-2030)
5 Segment by Application
5.1 Global Fluralaner API Sales by Application (2019-2030)
5.1.1 Global Fluralaner API Sales by Application (2019-2024)
5.1.2 Global Fluralaner API Sales by Application (2025-2030)
5.1.3 Global Fluralaner API Sales Market Share by Application (2019-2030)
5.2 Global Fluralaner API Revenue by Application (2019-2030)
5.2.1 Global Fluralaner API Revenue by Application (2019-2024)
5.2.2 Global Fluralaner API Revenue by Application (2025-2030)
5.2.3 Global Fluralaner API Revenue Market Share by Application (2019-2030)
5.3 Global Fluralaner API Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Nissan Chemical
6.1.1 Nissan Chemical Corporation Information
6.1.2 Nissan Chemical Description and Business Overview
6.1.3 Nissan Chemical Fluralaner API Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Nissan Chemical Fluralaner API Product Portfolio
6.1.5 Nissan Chemical Recent Developments/Updates
6.2 Hikal
6.2.1 Hikal Corporation Information
6.2.2 Hikal Description and Business Overview
6.2.3 Hikal Fluralaner API Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Hikal Fluralaner API Product Portfolio
6.2.5 Hikal Recent Developments/Updates
6.3 Hubei Masteam Bio-tech
6.3.1 Hubei Masteam Bio-tech Corporation Information
6.3.2 Hubei Masteam Bio-tech Description and Business Overview
6.3.3 Hubei Masteam Bio-tech Fluralaner API Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Hubei Masteam Bio-tech Fluralaner API Product Portfolio
6.3.5 Hubei Masteam Bio-tech Recent Developments/Updates
6.4 Jiangsu Rivocean
6.4.1 Jiangsu Rivocean Corporation Information
6.4.2 Jiangsu Rivocean Description and Business Overview
6.4.3 Jiangsu Rivocean Fluralaner API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Jiangsu Rivocean Fluralaner API Product Portfolio
6.4.5 Jiangsu Rivocean Recent Developments/Updates
6.5 Shaanxi Dideu
6.5.1 Shaanxi Dideu Corporation Information
6.5.2 Shaanxi Dideu Description and Business Overview
6.5.3 Shaanxi Dideu Fluralaner API Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Shaanxi Dideu Fluralaner API Product Portfolio
6.5.5 Shaanxi Dideu Recent Developments/Updates
6.6 Zhejiang Gihi Chemicals
6.6.1 Zhejiang Gihi Chemicals Corporation Information
6.6.2 Zhejiang Gihi Chemicals Description and Business Overview
6.6.3 Zhejiang Gihi Chemicals Fluralaner API Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Zhejiang Gihi Chemicals Fluralaner API Product Portfolio
6.6.5 Zhejiang Gihi Chemicals Recent Developments/Updates
6.7 Hunan Huateng Pharmaceutical
6.6.1 Hunan Huateng Pharmaceutical Corporation Information
6.6.2 Hunan Huateng Pharmaceutical Description and Business Overview
6.6.3 Hunan Huateng Pharmaceutical Fluralaner API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hunan Huateng Pharmaceutical Fluralaner API Product Portfolio
6.7.5 Hunan Huateng Pharmaceutical Recent Developments/Updates
6.8 Taizhou Crene Biotechnology
6.8.1 Taizhou Crene Biotechnology Corporation Information
6.8.2 Taizhou Crene Biotechnology Description and Business Overview
6.8.3 Taizhou Crene Biotechnology Fluralaner API Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Taizhou Crene Biotechnology Fluralaner API Product Portfolio
6.8.5 Taizhou Crene Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fluralaner API Industry Chain Analysis
7.2 Fluralaner API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fluralaner API Production Mode & Process
7.4 Fluralaner API Sales and Marketing
7.4.1 Fluralaner API Sales Channels
7.4.2 Fluralaner API Distributors
7.5 Fluralaner API Customers
8 Fluralaner API Market Dynamics
8.1 Fluralaner API Industry Trends
8.2 Fluralaner API Market Drivers
8.3 Fluralaner API Market Challenges
8.4 Fluralaner API Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
